Peptic Ulcer Hemorrhage Clinical Trial
— CSEOfficial title:
The Selection Criteria for Deciding Who Needs the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers
NCT number | NCT02197039 |
Other study ID # | A-ER-103-112 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | August 2011 |
Est. completion date | July 2014 |
Verified date | July 2014 |
Source | National Cheng-Kung University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
The purpose of this prospective study is to identify risk factors which could predict poor fading of SRH or early recurrent bleeding of peptic ulcer hemorrhage after successful endoscopic hemostasis and high-dose PPI infusion. These risk factors will be the selection criteria for patients who are indicated to receive second-look endoscopy.
Status | Completed |
Enrollment | 316 |
Est. completion date | July 2014 |
Est. primary completion date | July 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 95 Years |
Eligibility | Inclusion Criteria: - Bleeding peptic ulcers with major stigmata of recent hemorrhage - All of these major SRH are treated by local injection of diluted epinephrine 1:10000 with or without combined therapy with a heater probe, argon plasma coagulation, band ligation, or hemoclip therapy Exclusion Criteria: - Bleeding due to tumor or cancer - Bleeding due to the presence of a Dieulafoy lesion - Ulcer bleeding due to mechanical factors (i.e., gastrostomy tube induction) - Proton pump inhibitors use within one week before enrollment - Failure to establish hemostasis under gastroscopy - Hypersensitivity to esomeprazole, pantoprazole, or any component of the formulation - Previously participated in the study |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Cheng Kung University Hospital | Tainan |
Lead Sponsor | Collaborator |
---|---|
National Cheng-Kung University Hospital | National Science Council, Taiwan |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the fading rate of major stigmata of recent hemorrhage | At the index gastroscopy, bleeding ulcers are checked. All of the major stigmata of recent hemorrhage (SRH) are treated by one or a combination of endoscopic therapies. The success of endoscopic hemostasis is defined as cessation of bleeding together with achievement of cavitation at the vessel after application of the heater probe.
Second-look endoscopy is scheduled 48-72 hours after successful index endoscopic hemostasis and intravenous high-dose proton pump inhibitor infusion. For each patient with either suspected or active recurrent bleeding, emergent endoscopy is conducted earlier before the schedule to confirm peptic ulcer recurrent bleeding. Possible risk factors including patient's baseline clinical, laboratory characteristics, and gastroscopic pictures are obtained at the time of admission. Multiple logistic regression analysis is applied to assess the independent risk factors related to residual major stigmata or early recurrent bleeding of peptic ulcers. |
within 3 days after the index gastroscopy |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01125852 -
Supplementary Angiographic Embolization for Peptic Ulcer Bleeding
|
N/A | |
Completed |
NCT00840008 -
The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding
|
Phase 4 | |
Terminated |
NCT00164905 -
Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage
|
N/A | |
Completed |
NCT05563714 -
Anticoagulation With Enhanced Gastrointestinal Safety
|
N/A | |
Completed |
NCT03362281 -
Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
|
Phase 3 | |
Completed |
NCT00164931 -
A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer
|
Phase 3 | |
Completed |
NCT04211194 -
Registry for Upper Gastrointestinal Bleeding
|
||
Completed |
NCT01241266 -
China Survey of Peptic Ulcer Bleeding
|
N/A | |
Completed |
NCT00037570 -
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
|
Phase 2 | |
Completed |
NCT00731601 -
Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding
|
Phase 4 | |
Completed |
NCT05248321 -
Precise Delivery of Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer Bleeding
|
N/A | |
Recruiting |
NCT00687336 -
Helicobacter Pylori Empiric Treatment in Ulcer Bleeding
|
Phase 4 | |
Not yet recruiting |
NCT06273384 -
Diagnostic Performance of CIM for Helicobacter Pylori Infection in Patients With Peptic Ulcer Bleeding
|
||
Terminated |
NCT00165009 -
Resolution Endoclips Vs Epinephrine Injection and Heater Probe
|
Phase 3 | |
Completed |
NCT03163680 -
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
|
||
Completed |
NCT00279123 -
Effects of 2 Different Doses of Pantoprazole on Gastric pH and Recurrent Bleeding in Patients Who Bled From Peptic Ulcers
|
Phase 4 | |
Completed |
NCT03362268 -
IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
|
Phase 2 | |
Completed |
NCT00573924 -
Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers
|
N/A | |
Withdrawn |
NCT02724150 -
Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
|
Phase 4 | |
Active, not recruiting |
NCT04536428 -
ClearEndoclip Versus EZ Clip for Upper Gastrointestinal Ulcer Bleeding
|
N/A |